IBDEI271 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35030,1,4,0)
 ;;=4^G81.92
 ;;^UTILITY(U,$J,358.3,35030,2)
 ;;=^5004122
 ;;^UTILITY(U,$J,358.3,35031,0)
 ;;=G81.94^^137^1792^7
 ;;^UTILITY(U,$J,358.3,35031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35031,1,3,0)
 ;;=3^Hemiplegia,Unspec Affecting Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,35031,1,4,0)
 ;;=4^G81.94
 ;;^UTILITY(U,$J,358.3,35031,2)
 ;;=^5004124
 ;;^UTILITY(U,$J,358.3,35032,0)
 ;;=G81.91^^137^1792^8
 ;;^UTILITY(U,$J,358.3,35032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35032,1,3,0)
 ;;=3^Hemiplegia,Unspec Affecting Right Dominant Side
 ;;^UTILITY(U,$J,358.3,35032,1,4,0)
 ;;=4^G81.91
 ;;^UTILITY(U,$J,358.3,35032,2)
 ;;=^5004121
 ;;^UTILITY(U,$J,358.3,35033,0)
 ;;=G81.93^^137^1792^9
 ;;^UTILITY(U,$J,358.3,35033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35033,1,3,0)
 ;;=3^Hemiplegia,Unspec Affecting Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,35033,1,4,0)
 ;;=4^G81.93
 ;;^UTILITY(U,$J,358.3,35033,2)
 ;;=^5004123
 ;;^UTILITY(U,$J,358.3,35034,0)
 ;;=I69.942^^137^1792^22
 ;;^UTILITY(U,$J,358.3,35034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35034,1,3,0)
 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Dominant Side
 ;;^UTILITY(U,$J,358.3,35034,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,35034,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,35035,0)
 ;;=I69.944^^137^1792^23
 ;;^UTILITY(U,$J,358.3,35035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35035,1,3,0)
 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,35035,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,35035,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,35036,0)
 ;;=I69.941^^137^1792^24
 ;;^UTILITY(U,$J,358.3,35036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35036,1,3,0)
 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Dominant Side
 ;;^UTILITY(U,$J,358.3,35036,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,35036,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,35037,0)
 ;;=I69.943^^137^1792^25
 ;;^UTILITY(U,$J,358.3,35037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35037,1,3,0)
 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,35037,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,35037,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,35038,0)
 ;;=G35.^^137^1792^26
 ;;^UTILITY(U,$J,358.3,35038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35038,1,3,0)
 ;;=3^Multiple sclerosis
 ;;^UTILITY(U,$J,358.3,35038,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,35038,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,35039,0)
 ;;=G20.^^137^1792^27
 ;;^UTILITY(U,$J,358.3,35039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35039,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,35039,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,35039,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,35040,0)
 ;;=R56.9^^137^1792^3
 ;;^UTILITY(U,$J,358.3,35040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35040,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,35040,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,35040,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,35041,0)
 ;;=S06.9X5S^^137^1792^14
 ;;^UTILITY(U,$J,358.3,35041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35041,1,3,0)
 ;;=3^Intcrn injury w LOC >24 hr w ret consc lev, sequela
 ;;^UTILITY(U,$J,358.3,35041,1,4,0)
 ;;=4^S06.9X5S
 ;;^UTILITY(U,$J,358.3,35041,2)
 ;;=^5021223
 ;;^UTILITY(U,$J,358.3,35042,0)
 ;;=S06.9X6S^^137^1792^15
 ;;^UTILITY(U,$J,358.3,35042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35042,1,3,0)
 ;;=3^Intcrn injury w LOC >24 hr w/o ret consc w surv, sqla
